1. Home
  2. SKIN vs ENTA Comparison

SKIN vs ENTA Comparison

Compare SKIN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKIN
  • ENTA
  • Stock Information
  • Founded
  • SKIN 1997
  • ENTA 1995
  • Country
  • SKIN United States
  • ENTA United States
  • Employees
  • SKIN N/A
  • ENTA N/A
  • Industry
  • SKIN Package Goods/Cosmetics
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKIN Consumer Discretionary
  • ENTA Health Care
  • Exchange
  • SKIN Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • SKIN 164.1M
  • ENTA 154.0M
  • IPO Year
  • SKIN N/A
  • ENTA 2013
  • Fundamental
  • Price
  • SKIN $1.34
  • ENTA $5.59
  • Analyst Decision
  • SKIN Hold
  • ENTA Buy
  • Analyst Count
  • SKIN 5
  • ENTA 4
  • Target Price
  • SKIN $2.50
  • ENTA $17.25
  • AVG Volume (30 Days)
  • SKIN 730.8K
  • ENTA 228.9K
  • Earning Date
  • SKIN 03-12-2025
  • ENTA 05-05-2025
  • Dividend Yield
  • SKIN N/A
  • ENTA N/A
  • EPS Growth
  • SKIN N/A
  • ENTA N/A
  • EPS
  • SKIN N/A
  • ENTA N/A
  • Revenue
  • SKIN $334,294,000.00
  • ENTA $66,590,999.00
  • Revenue This Year
  • SKIN $1.93
  • ENTA N/A
  • Revenue Next Year
  • SKIN $12.41
  • ENTA N/A
  • P/E Ratio
  • SKIN N/A
  • ENTA N/A
  • Revenue Growth
  • SKIN N/A
  • ENTA N/A
  • 52 Week Low
  • SKIN $0.91
  • ENTA $4.71
  • 52 Week High
  • SKIN $4.48
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • SKIN 45.76
  • ENTA 31.66
  • Support Level
  • SKIN $1.25
  • ENTA $5.65
  • Resistance Level
  • SKIN $1.45
  • ENTA $5.96
  • Average True Range (ATR)
  • SKIN 0.11
  • ENTA 0.36
  • MACD
  • SKIN 0.01
  • ENTA -0.15
  • Stochastic Oscillator
  • SKIN 34.29
  • ENTA 4.77

About SKIN The Beauty Health Company

The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: